Show an ad over header. AMP

I am the FIRST!!!

Only 4.3 million vaccine doses have been administered in the U.S.

The vaccine rollout is not going as planned so far, and has run headfirst into resource shortages and staffing issues caused by the raging pandemic.

Why it matters: The Trump administration's goal of vaccinating 20 million people by the end of year fell drastically short, raising concerns about how long it may be until enough people are vaccinated in the U.S. for life to return to normal.


By the numbers: 1.3% of the U.S. population has been vaccinated and 33% of the shots distributed to states have been administered, according to a Bloomberg analysis of CDC data.

  • Operation Warp Speed has distributed 13 million doses, about 7 million doses short of its goal. About 4.3 million doses have been administered.

The state of play: State officials have given several reasons for why vaccinations have moved at a slower-than-expected pace, per the New York Times.

  • The surge in coronavirus cases, hospitalizations and deaths have overwhelmed health care facilities, hindering their ability to deliver vaccines.
  • Many states have reserved vaccine doses for nursing homes and long-term care facilities, slowing distribution.
  • The holidays also led to reduced hours and limited staffing in clinics.

Yes, but: NIAID director Anthony Fauci said Sunday on ABC's "This Week" that he has seen "some little glimmer of hope" after 1.5 million doses were administered in the previous 72 hours, a marked increase in the vaccination rate.

In light of this slow rollout, some experts want to simply prioritize getting more shots in arms — regardless of which arms those are — as the pandemic worsens.

Driving the news: The head of Operation Warp Speed, Moncef Slaoui, said yesterday that the administration is considering halving the dose of each shot of the Moderna vaccine to double the number of people who could get it, per NYT.

And some experts are arguing that second shots should be delayed.

  • "It's time to change the plan; namely, we should give people a single vaccination now and defer their second shot until more doses of vaccine become available," UCSF's Robert Wachter and Brown's Ashish Jha wrote yesterday in a Washington Post op-ed.

The Texas health department recently sent a letter to vaccine providers urging them to vaccinate as many people as possible, as quickly as possible.

  • "If, in a given situation, all readily available and willing 1A and 1B persons have been served, we urge you to pivot again and provide vaccine to any additional available and willing persons, regardless of their priority designation," the commissioner wrote.

The bottom line: "A vaccine that’s sitting on a shelf for weeks, waiting for its perfect recipient, doesn’t help snuff out the pandemic," former FDA Commissioner Scott Gottlieb wrote in a WSJ op-ed.

regular 4 post ff

infinite scroll 4 pff

Rudy Giuliani rails against Black Lives Matter, Antifa and De Blasio in RNC speech

President Trump's personal attorney Rudy Giuliani took on the "unprecedented wave of lawlessness" that has swept across the U.S. at the RNC Thursday night, accusing the Black Lives Matter movement and Antifa of turning peaceful protests into "vicious, brutal riots."

Why it matters: As mayor of New York City, Giuliani was famous for championing a controversial record of crime-fighting, including policies like stop-and-frisk. He tore into his successor Bill De Blasio for allowing crime to rise in New York, and accused Joe Biden of being a "Trojan horse" for progressives "waiting to execute their pro-criminal, anti-police, socialist policies."

Keep reading...Show less

Gene editing pioneers win Nobel Prize in chemistry

Jennifer Doudna and Emmanuelle Charpentier won the Nobel Prize in chemistry on Wednesday for their work developing the gene editing tool CRISPR.

Why it matters: Gene editing could transform biology and medicine with its wide-ranging applications for understanding and treating disease, optimizing crops and eradicating pests. But its potential use in treating human diseases by changing genes that can be inherited raises major ethical questions that will challenge scientists for decades.

Keep reading...Show less

Rep. Horsford to lead Congressional Black Caucus transition

Rep. Steven Horsford (D-Nev.) will serve as a liaison between the Congressional Black Caucus (CBC) and President-elect Joe Biden's transition team, pushing for their caucus' interests to be heard by the incoming administration, as the head of the CBC's first 100 days task force, two sources familiar tell Axios and his office confirmed.

Why it matters: His role helps give the CBC more collective power when presenting personnel and policy recommendations to Biden's team. It comes at particularly crucial time when the transition team is starting to make staffing decisions and several lawmakers are publicly and privately lobbying for representation in his Cabinet and throughout the administration.

Keep reading...Show less

China's political power grows with its capital markets

Thanks to a mandate for outside investment and its strong rebound from the coronavirus pandemic, China’s financial markets are drawing record high chunks of global capital — particularly from U.S.-based investors — and are poised to keep growing.

Why it matters: As more money flows to China’s markets, its political leaders will have a clear mechanism to increase the country’s political power, giving China another potent weapon to challenge the United States’ position as the world’s financial superpower.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;